Winton Group LTD Regeneron Pharmaceuticals, Inc. Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

A detailed history of Winton Group LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Winton Group LTD holds 1,068 shares of REGN stock, worth $831,438. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,068

Holding current value

$831,438

% of portfolio

0.09%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $1.09 Million - $1.28 Million	1,068 New	1,068 $1.12 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $194,981 - $214,563	-216 Reduced 4.43%	4,664 $4.49 Million
Q4 2023 Feb 12, 2024	SELL	$775.18 - $881.7 $806,187 - $916,968	-1,040 Reduced 17.57%	4,880 $4.29 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $990,895 - $1.21 Million	-1,431 Reduced 19.47%	5,920 $4.87 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $1.94 Million - $2.3 Million	2,766 Added 60.33%	7,351 $5.28 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $568,209 - $690,519	-835 Reduced 15.41%	4,585 $3.77 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $1.51 Million - $1.64 Million	2,143 Added 65.4%	5,420 $3.91 Million
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $3.59 Million - $4.53 Million	-6,249 Reduced 65.6%	3,277 $2.26 Million
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $1.55 Million - $2.09 Million	2,822 Added 42.09%	9,526 $5.63 Million
Q1 2022 May 11, 2022	BUY	$595.12 - $698.43 $1.93 Million - $2.27 Million	3,251 Added 94.15%	6,704 $4.68 Million
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $234,239 - $289,188	431 Added 14.26%	3,453 $2.18 Million
Q3 2021 Oct 28, 2021	BUY	$574.03 - $680.96 $181,393 - $215,183	316 Added 11.68%	3,022 $1.83 Million
Q2 2021 Aug 10, 2021	SELL	$472.8 - $558.54 $454,833 - $537,315	-962 Reduced 26.23%	2,706 $1.51 Million
Q1 2021 Jul 21, 2021	SELL	$446.73 - $548.2 $163,056 - $200,093	-365 Reduced 9.05%	3,668 $1.74 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $3.42 Million - $4.35 Million	-7,151 Reduced 63.94%	4,033 $1.95 Million
Q3 2020 Oct 30, 2020	SELL	$544.75 - $658.21 $3.36 Million - $4.06 Million	-6,171 Reduced 35.56%	11,184 $6.26 Million
Q2 2020 Aug 05, 2020	SELL	$493.32 - $643.92 $632,436 - $825,505	-1,282 Reduced 6.88%	17,355 $10.8 Million
Q1 2020 May 11, 2020	BUY	$336.18 - $494.43 $2.12 Million - $3.12 Million	6,318 Added 51.29%	18,637 $9.1 Million
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $16.4 Million - $22.6 Million	-59,977 Reduced 82.96%	12,319 $4.63 Million
Q3 2019 Nov 08, 2019	BUY	$273.46 - $318.39 $12.3 Million - $14.3 Million	44,930 Added 164.18%	72,296 $20.1 Million
Q2 2019 Jul 08, 2019	SELL	$299.6 - $414.82 $4.62 Million - $6.4 Million	-15,423 Reduced 36.04%	27,366 $8.57 Million
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $4.82 Million - $5.69 Million	12,946 Added 43.38%	42,789 $17.6 Million
Q4 2018 Feb 05, 2019	BUY	$335.82 - $403.04 $5.31 Million - $6.37 Million	15,802 Added 112.54%	29,843 $11.1 Million
Q3 2018 Nov 02, 2018	BUY	$351.14 - $408.51 $4.93 Million - $5.74 Million	14,041 New	14,041 $0
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $4.14 Million - $5.42 Million	-11,543 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $4.35 Million - $5.09 Million	10,092 Added 695.52%	11,543 $5.16 Million
Q2 2017 Aug 17, 2017	BUY	N/A	1,451	1,451 $713,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $83.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account